nodes	percent_of_prediction	percent_of_DWPC	metapath
Niacin—CYP2D6—Lomustine—brain cancer	0.108	0.569	CbGbCtD
Niacin—CYP2D6—Hydroxyurea—brain cancer	0.0815	0.431	CbGbCtD
Niacin—HCAR3—endocrine gland—brain cancer	0.013	0.0607	CbGeAlD
Niacin—SLC16A3—Pyruvate metabolism—BSG—brain cancer	0.0109	0.0569	CbGpPWpGaD
Niacin—SLC16A3—Basigin interactions—BSG—brain cancer	0.0106	0.0551	CbGpPWpGaD
Niacin—SLC16A3—hindbrain—brain cancer	0.0103	0.0481	CbGeAlD
Niacin—QPRT—endocrine gland—brain cancer	0.0103	0.048	CbGeAlD
Niacin—QPRT—head—brain cancer	0.0101	0.0474	CbGeAlD
Niacin—QPRT—central nervous system—brain cancer	0.00924	0.0432	CbGeAlD
Niacin—HCAR2—endocrine gland—brain cancer	0.0086	0.0402	CbGeAlD
Niacin—QPRT—brain—brain cancer	0.00734	0.0343	CbGeAlD
Niacin—SLCO2B1—ganglion—brain cancer	0.00709	0.0332	CbGeAlD
Niacin—SLC16A3—Pyruvate metabolism and Citric Acid (TCA) cycle—BSG—brain cancer	0.00662	0.0344	CbGpPWpGaD
Niacin—NNMT—pituitary gland—brain cancer	0.00624	0.0292	CbGeAlD
Niacin—NNMT—medulla oblongata—brain cancer	0.00602	0.0282	CbGeAlD
Niacin—SLC16A1—Pyruvate metabolism—BSG—brain cancer	0.00591	0.0307	CbGpPWpGaD
Niacin—SLC16A3—brainstem—brain cancer	0.0059	0.0276	CbGeAlD
Niacin—SLC16A1—Basigin interactions—BSG—brain cancer	0.00572	0.0297	CbGpPWpGaD
Niacin—NNMT—midbrain—brain cancer	0.00551	0.0257	CbGeAlD
Niacin—NNMT—Biological oxidations—CYP2C9—brain cancer	0.00545	0.0283	CbGpPWpGaD
Niacin—NNMT—Metapathway biotransformation—CYP2C9—brain cancer	0.00538	0.028	CbGpPWpGaD
Niacin—NNMT—spinal cord—brain cancer	0.00537	0.0251	CbGeAlD
Niacin—SLC16A3—telencephalon—brain cancer	0.00524	0.0245	CbGeAlD
Niacin—NNMT—endocrine gland—brain cancer	0.00484	0.0226	CbGeAlD
Niacin—NNMT—head—brain cancer	0.00477	0.0223	CbGeAlD
Niacin—SLC16A3—gonad—brain cancer	0.00437	0.0204	CbGeAlD
Niacin—NNMT—central nervous system—brain cancer	0.00436	0.0204	CbGeAlD
Niacin—SLC16A3—pituitary gland—brain cancer	0.00426	0.0199	CbGeAlD
Niacin—NNMT—cerebellum—brain cancer	0.00426	0.0199	CbGeAlD
Niacin—SLC16A3—medulla oblongata—brain cancer	0.00411	0.0192	CbGeAlD
Niacin—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.00361	0.0188	CbGpPWpGaD
Niacin—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—BSG—brain cancer	0.00358	0.0186	CbGpPWpGaD
Niacin—SLC16A3—Cell surface interactions at the vascular wall—BSG—brain cancer	0.00352	0.0183	CbGpPWpGaD
Niacin—Salicylic acid—CYP2C9—brain cancer	0.00351	1	CrCbGaD
Niacin—NNMT—brain—brain cancer	0.00346	0.0162	CbGeAlD
Niacin—SLC16A3—endocrine gland—brain cancer	0.0033	0.0154	CbGeAlD
Niacin—SLC16A3—head—brain cancer	0.00326	0.0152	CbGeAlD
Niacin—SLC16A1—telencephalon—brain cancer	0.00318	0.0149	CbGeAlD
Niacin—SLC16A3—central nervous system—brain cancer	0.00298	0.0139	CbGeAlD
Niacin—SLC16A3—cerebellum—brain cancer	0.00291	0.0136	CbGeAlD
Niacin—SLCO2B1—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.00283	0.0147	CbGpPWpGaD
Niacin—SLCO2B1—telencephalon—brain cancer	0.00274	0.0128	CbGeAlD
Niacin—HCAR2—GPCR ligand binding—PTCH2—brain cancer	0.00271	0.0141	CbGpPWpGaD
Niacin—SLC16A1—gonad—brain cancer	0.00265	0.0124	CbGeAlD
Niacin—SLC16A1—pituitary gland—brain cancer	0.00259	0.0121	CbGeAlD
Niacin—HCAR3—GPCR ligand binding—PTCH2—brain cancer	0.00257	0.0134	CbGpPWpGaD
Niacin—SLC16A3—The citric acid (TCA) cycle and respiratory electron transport—BSG—brain cancer	0.00257	0.0133	CbGpPWpGaD
Niacin—SLC16A1—medulla oblongata—brain cancer	0.0025	0.0117	CbGeAlD
Niacin—Rash maculo-papular—Hydroxyurea—brain cancer	0.00246	0.00613	CcSEcCtD
Niacin—Alopecia—Lomustine—brain cancer	0.00244	0.00609	CcSEcCtD
Niacin—Breast pain—Temozolomide—brain cancer	0.00242	0.00604	CcSEcCtD
Niacin—SLC5A8—Transmembrane transport of small molecules—S100A10—brain cancer	0.0024	0.0125	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—OR14C36—brain cancer	0.00238	0.0124	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—OR4C12—brain cancer	0.00238	0.0124	CbGpPWpGaD
Niacin—SLC16A3—brain—brain cancer	0.00236	0.011	CbGeAlD
Niacin—Hyperbilirubinaemia—Temozolomide—brain cancer	0.00233	0.0058	CcSEcCtD
Niacin—CYP2D6—hindbrain—brain cancer	0.00231	0.0108	CbGeAlD
Niacin—SLC16A1—midbrain—brain cancer	0.00228	0.0107	CbGeAlD
Niacin—Laryngospasm—Etoposide—brain cancer	0.00227	0.00565	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—OR4C12—brain cancer	0.00226	0.0117	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—OR14C36—brain cancer	0.00226	0.0117	CbGpPWpGaD
Niacin—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.00224	0.0116	CbGpPWpGaD
Niacin—SLC16A1—spinal cord—brain cancer	0.00223	0.0104	CbGeAlD
Niacin—Dysphagia—Procarbazine—brain cancer	0.00219	0.00547	CcSEcCtD
Niacin—Hepatotoxicity—Etoposide—brain cancer	0.00219	0.00546	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—OR4C12—brain cancer	0.00216	0.0112	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—OR14C36—brain cancer	0.00216	0.0112	CbGpPWpGaD
Niacin—Necrosis—Etoposide—brain cancer	0.00216	0.00537	CcSEcCtD
Niacin—Leukopenia—Lomustine—brain cancer	0.00216	0.00537	CcSEcCtD
Niacin—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00215	0.0112	CbGpPWpGaD
Niacin—SLCO2B1—medulla oblongata—brain cancer	0.00215	0.0101	CbGeAlD
Niacin—Angina pectoris—Procarbazine—brain cancer	0.00214	0.00533	CcSEcCtD
Niacin—Vaginal inflammation—Temozolomide—brain cancer	0.00211	0.00527	CcSEcCtD
Niacin—Tingling sensation—Etoposide—brain cancer	0.00211	0.00525	CcSEcCtD
Niacin—Skin exfoliation—Carmustine—brain cancer	0.00209	0.00521	CcSEcCtD
Niacin—Dermatitis bullous—Hydroxyurea—brain cancer	0.00206	0.00512	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—OR4C12—brain cancer	0.00205	0.0106	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—OR14C36—brain cancer	0.00205	0.0106	CbGpPWpGaD
Niacin—Skin exfoliation—Temozolomide—brain cancer	0.00202	0.00503	CcSEcCtD
Niacin—SLC16A1—endocrine gland—brain cancer	0.00201	0.00938	CbGeAlD
Niacin—Vaginal infection—Temozolomide—brain cancer	0.002	0.00498	CcSEcCtD
Niacin—SLC16A1—head—brain cancer	0.00198	0.00926	CbGeAlD
Niacin—Pain—Carboplatin—brain cancer	0.00192	0.00479	CcSEcCtD
Niacin—SLCO2B1—spinal cord—brain cancer	0.00192	0.00896	CbGeAlD
Niacin—Abnormal vision—Carmustine—brain cancer	0.00191	0.00476	CcSEcCtD
Niacin—Stomatitis—Procarbazine—brain cancer	0.00191	0.00475	CcSEcCtD
Niacin—Jaundice—Procarbazine—brain cancer	0.00191	0.00475	CcSEcCtD
Niacin—SLC16A1—Cell surface interactions at the vascular wall—BSG—brain cancer	0.0019	0.00989	CbGpPWpGaD
Niacin—Face oedema—Hydroxyurea—brain cancer	0.0019	0.00473	CcSEcCtD
Niacin—Sweating—Procarbazine—brain cancer	0.00188	0.00468	CcSEcCtD
Niacin—Anorexia—Lomustine—brain cancer	0.00187	0.00467	CcSEcCtD
Niacin—Skin discolouration—Etoposide—brain cancer	0.00187	0.00467	CcSEcCtD
Niacin—Abnormal vision—Temozolomide—brain cancer	0.00184	0.0046	CcSEcCtD
Niacin—Diabetes mellitus—Carmustine—brain cancer	0.00183	0.00455	CcSEcCtD
Niacin—Hyperuricaemia—Etoposide—brain cancer	0.00182	0.00455	CcSEcCtD
Niacin—SLC16A1—central nervous system—brain cancer	0.00181	0.00845	CbGeAlD
Niacin—Body temperature increased—Carboplatin—brain cancer	0.00178	0.00443	CcSEcCtD
Niacin—QPRT—Disease—DTX2—brain cancer	0.00177	0.00922	CbGpPWpGaD
Niacin—SLC16A1—cerebellum—brain cancer	0.00177	0.00826	CbGeAlD
Niacin—Haemoglobin—Procarbazine—brain cancer	0.00177	0.0044	CcSEcCtD
Niacin—Haemorrhage—Procarbazine—brain cancer	0.00176	0.00438	CcSEcCtD
Niacin—SLCO2B1—endocrine gland—brain cancer	0.00173	0.00807	CbGeAlD
Niacin—Blood uric acid increased—Etoposide—brain cancer	0.00172	0.0043	CcSEcCtD
Niacin—Decreased appetite—Lomustine—brain cancer	0.00171	0.00426	CcSEcCtD
Niacin—SLCO2B1—head—brain cancer	0.0017	0.00797	CbGeAlD
Niacin—Flushing—Procarbazine—brain cancer	0.00163	0.00406	CcSEcCtD
Niacin—Skin exfoliation—Etoposide—brain cancer	0.00162	0.00403	CcSEcCtD
Niacin—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.00159	0.00396	CcSEcCtD
Niacin—Chills—Procarbazine—brain cancer	0.00158	0.00393	CcSEcCtD
Niacin—Arrhythmia—Procarbazine—brain cancer	0.00157	0.00391	CcSEcCtD
Niacin—SLCO2B1—central nervous system—brain cancer	0.00156	0.00727	CbGeAlD
Niacin—Body temperature increased—Lomustine—brain cancer	0.00155	0.00387	CcSEcCtD
Niacin—Alopecia—Procarbazine—brain cancer	0.00155	0.00387	CcSEcCtD
Niacin—Oesophagitis—Etoposide—brain cancer	0.00155	0.00385	CcSEcCtD
Niacin—Rash maculo-papular—Etoposide—brain cancer	0.00154	0.00383	CcSEcCtD
Niacin—Face oedema—Carmustine—brain cancer	0.00153	0.00382	CcSEcCtD
Niacin—SLCO2B1—cerebellum—brain cancer	0.00152	0.00711	CbGeAlD
Niacin—Tension—Procarbazine—brain cancer	0.0015	0.00374	CcSEcCtD
Niacin—Nervousness—Procarbazine—brain cancer	0.00149	0.0037	CcSEcCtD
Niacin—Face oedema—Temozolomide—brain cancer	0.00148	0.00369	CcSEcCtD
Niacin—SLC22A5—pituitary gland—brain cancer	0.00148	0.00692	CbGeAlD
Niacin—Stomatitis—Hydroxyurea—brain cancer	0.00148	0.00368	CcSEcCtD
Niacin—Liver function test abnormal—Carmustine—brain cancer	0.00147	0.00366	CcSEcCtD
Niacin—SLC16A1—brain—brain cancer	0.00144	0.00671	CbGeAlD
Niacin—SLC22A5—medulla oblongata—brain cancer	0.00143	0.00668	CbGeAlD
Niacin—SLC16A3—Hemostasis—MPL—brain cancer	0.00141	0.00735	CbGpPWpGaD
Niacin—Dry skin—Temozolomide—brain cancer	0.00141	0.00351	CcSEcCtD
Niacin—Muscular weakness—Carmustine—brain cancer	0.0014	0.00349	CcSEcCtD
Niacin—HCAR2—GPCR ligand binding—SHH—brain cancer	0.0014	0.00727	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PTCH2—brain cancer	0.00139	0.00724	CbGpPWpGaD
Niacin—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—BSG—brain cancer	0.00139	0.00721	CbGpPWpGaD
Niacin—Dysphagia—Carmustine—brain cancer	0.00137	0.00342	CcSEcCtD
Niacin—Syncope—Procarbazine—brain cancer	0.00137	0.00342	CcSEcCtD
Niacin—Leukopenia—Procarbazine—brain cancer	0.00137	0.00341	CcSEcCtD
Niacin—Haemoglobin—Hydroxyurea—brain cancer	0.00137	0.00341	CcSEcCtD
Niacin—Haemorrhage—Hydroxyurea—brain cancer	0.00136	0.00339	CcSEcCtD
Niacin—SLC16A3—Hemostasis—S100A10—brain cancer	0.00136	0.00705	CbGpPWpGaD
Niacin—Muscular weakness—Temozolomide—brain cancer	0.00135	0.00337	CcSEcCtD
Niacin—Loss of consciousness—Procarbazine—brain cancer	0.00134	0.00335	CcSEcCtD
Niacin—Abdominal distension—Temozolomide—brain cancer	0.00134	0.00333	CcSEcCtD
Niacin—Cough—Procarbazine—brain cancer	0.00133	0.00333	CcSEcCtD
Niacin—Dysphagia—Temozolomide—brain cancer	0.00133	0.00331	CcSEcCtD
Niacin—HCAR3—GPCR ligand binding—SHH—brain cancer	0.00133	0.00689	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—PTCH1—brain cancer	0.00133	0.00689	CbGpPWpGaD
Niacin—HCAR2—GPCR ligand binding—SMO—brain cancer	0.00133	0.00689	CbGpPWpGaD
Niacin—CYP2D6—brainstem—brain cancer	0.00132	0.00618	CbGeAlD
Niacin—HCAR3—Signaling by GPCR—PTCH2—brain cancer	0.00132	0.00686	CbGpPWpGaD
Niacin—SLC22A5—midbrain—brain cancer	0.00131	0.0061	CbGeAlD
Niacin—Arthralgia—Procarbazine—brain cancer	0.0013	0.00324	CcSEcCtD
Niacin—Myalgia—Procarbazine—brain cancer	0.0013	0.00324	CcSEcCtD
Niacin—QPRT—Disease—HES5—brain cancer	0.0013	0.00677	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—OR14C36—brain cancer	0.00128	0.00664	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—OR4C12—brain cancer	0.00128	0.00664	CbGpPWpGaD
Niacin—Bronchitis—Temozolomide—brain cancer	0.00128	0.00318	CcSEcCtD
Niacin—SLC22A5—spinal cord—brain cancer	0.00127	0.00595	CbGeAlD
Niacin—Dry mouth—Procarbazine—brain cancer	0.00127	0.00317	CcSEcCtD
Niacin—HCAR3—GPCR ligand binding—PTCH1—brain cancer	0.00126	0.00653	CbGpPWpGaD
Niacin—HCAR3—GPCR ligand binding—SMO—brain cancer	0.00126	0.00653	CbGpPWpGaD
Niacin—Vomiting—Lomustine—brain cancer	0.00125	0.00312	CcSEcCtD
Niacin—Oedema—Procarbazine—brain cancer	0.00125	0.00311	CcSEcCtD
Niacin—SLCO2B1—brain—brain cancer	0.00123	0.00577	CbGeAlD
Niacin—Angiopathy—Hydroxyurea—brain cancer	0.00123	0.00307	CcSEcCtD
Niacin—Shock—Procarbazine—brain cancer	0.00123	0.00306	CcSEcCtD
Niacin—Erectile dysfunction—Temozolomide—brain cancer	0.00122	0.00305	CcSEcCtD
Niacin—Chills—Hydroxyurea—brain cancer	0.00122	0.00304	CcSEcCtD
Niacin—Tachycardia—Procarbazine—brain cancer	0.00122	0.00304	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—OR14C36—brain cancer	0.00121	0.00629	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—OR4C12—brain cancer	0.00121	0.00629	CbGpPWpGaD
Niacin—Hyperhidrosis—Procarbazine—brain cancer	0.00121	0.00301	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—ABR—brain cancer	0.0012	0.00625	CbGpPWpGaD
Niacin—Alopecia—Hydroxyurea—brain cancer	0.0012	0.00299	CcSEcCtD
Niacin—Stomatitis—Carmustine—brain cancer	0.00119	0.00297	CcSEcCtD
Niacin—Anorexia—Procarbazine—brain cancer	0.00119	0.00297	CcSEcCtD
Niacin—Erythema—Hydroxyurea—brain cancer	0.00118	0.00295	CcSEcCtD
Niacin—SLC16A3—Transmembrane transport of small molecules—S100A10—brain cancer	0.00117	0.0061	CbGpPWpGaD
Niacin—CYP2D6—telencephalon—brain cancer	0.00117	0.00548	CbGeAlD
Niacin—Nausea—Lomustine—brain cancer	0.00117	0.00291	CcSEcCtD
Niacin—Hypotension—Procarbazine—brain cancer	0.00117	0.00291	CcSEcCtD
Niacin—Stomatitis—Temozolomide—brain cancer	0.00115	0.00287	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—ABR—brain cancer	0.00114	0.00593	CbGpPWpGaD
Niacin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00114	0.00283	CcSEcCtD
Niacin—Insomnia—Procarbazine—brain cancer	0.00113	0.00281	CcSEcCtD
Niacin—Paraesthesia—Procarbazine—brain cancer	0.00112	0.00279	CcSEcCtD
Niacin—SLC5A8—Transmembrane transport of small molecules—TRPC6—brain cancer	0.00111	0.00577	CbGpPWpGaD
Niacin—Somnolence—Procarbazine—brain cancer	0.00111	0.00277	CcSEcCtD
Niacin—Haemoglobin—Carmustine—brain cancer	0.0011	0.00275	CcSEcCtD
Niacin—Haemorrhage—Carmustine—brain cancer	0.0011	0.00274	CcSEcCtD
Niacin—Hypoaesthesia—Carmustine—brain cancer	0.00109	0.00273	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—ABR—brain cancer	0.00109	0.00568	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—DTX2—brain cancer	0.00109	0.00564	CbGpPWpGaD
Niacin—Decreased appetite—Procarbazine—brain cancer	0.00108	0.0027	CcSEcCtD
Niacin—Oedema peripheral—Carmustine—brain cancer	0.00108	0.0027	CcSEcCtD
Niacin—Haemoglobin—Temozolomide—brain cancer	0.00107	0.00266	CcSEcCtD
Niacin—Pain—Procarbazine—brain cancer	0.00107	0.00266	CcSEcCtD
Niacin—Hepatitis—Temozolomide—brain cancer	0.00106	0.00265	CcSEcCtD
Niacin—Haemorrhage—Temozolomide—brain cancer	0.00106	0.00265	CcSEcCtD
Niacin—Dysphagia—Etoposide—brain cancer	0.00106	0.00265	CcSEcCtD
Niacin—Leukopenia—Hydroxyurea—brain cancer	0.00106	0.00264	CcSEcCtD
Niacin—Visual impairment—Carmustine—brain cancer	0.00106	0.00264	CcSEcCtD
Niacin—Hypoaesthesia—Temozolomide—brain cancer	0.00106	0.00263	CcSEcCtD
Niacin—Oedema peripheral—Temozolomide—brain cancer	0.00105	0.00261	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—ABR—brain cancer	0.00104	0.00538	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—DTX2—brain cancer	0.00103	0.00535	CbGpPWpGaD
Niacin—Eye disorder—Carmustine—brain cancer	0.00103	0.00256	CcSEcCtD
Niacin—Visual impairment—Temozolomide—brain cancer	0.00102	0.00255	CcSEcCtD
Niacin—Gastrointestinal pain—Procarbazine—brain cancer	0.00102	0.00254	CcSEcCtD
Niacin—Flushing—Carmustine—brain cancer	0.00102	0.00254	CcSEcCtD
Niacin—SLC22A5—cerebellum—brain cancer	0.00101	0.00472	CbGeAlD
Niacin—QPRT—Metabolism—CYP2C9—brain cancer	0.001	0.00521	CbGpPWpGaD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.001	0.00249	CcSEcCtD
Niacin—Eye disorder—Temozolomide—brain cancer	0.000992	0.00247	CcSEcCtD
Niacin—Urticaria—Procarbazine—brain cancer	0.000991	0.00247	CcSEcCtD
Niacin—Tinnitus—Temozolomide—brain cancer	0.00099	0.00247	CcSEcCtD
Niacin—Body temperature increased—Procarbazine—brain cancer	0.000987	0.00246	CcSEcCtD
Niacin—Abdominal pain—Procarbazine—brain cancer	0.000987	0.00246	CcSEcCtD
Niacin—Flushing—Temozolomide—brain cancer	0.000986	0.00246	CcSEcCtD
Niacin—Arrhythmia—Carmustine—brain cancer	0.000982	0.00245	CcSEcCtD
Niacin—Alopecia—Carmustine—brain cancer	0.000971	0.00242	CcSEcCtD
Niacin—Oedema—Hydroxyurea—brain cancer	0.000966	0.00241	CcSEcCtD
Niacin—Angiopathy—Temozolomide—brain cancer	0.000964	0.0024	CcSEcCtD
Niacin—Erythema—Carmustine—brain cancer	0.000957	0.00238	CcSEcCtD
Niacin—Malnutrition—Carmustine—brain cancer	0.000957	0.00238	CcSEcCtD
Niacin—SLC16A3—Hemostasis—BSG—brain cancer	0.000955	0.00496	CbGpPWpGaD
Niacin—Chills—Temozolomide—brain cancer	0.000953	0.00238	CcSEcCtD
Niacin—Alopecia—Temozolomide—brain cancer	0.000938	0.00234	CcSEcCtD
Niacin—Skin disorder—Hydroxyurea—brain cancer	0.000938	0.00234	CcSEcCtD
Niacin—NNMT—Metabolism—CYP2C9—brain cancer	0.000933	0.00485	CbGpPWpGaD
Niacin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00093	0.00484	CbGpPWpGaD
Niacin—Erythema—Temozolomide—brain cancer	0.000925	0.0023	CcSEcCtD
Niacin—Malnutrition—Temozolomide—brain cancer	0.000925	0.0023	CcSEcCtD
Niacin—Stomatitis—Etoposide—brain cancer	0.000923	0.0023	CcSEcCtD
Niacin—Jaundice—Etoposide—brain cancer	0.000923	0.0023	CcSEcCtD
Niacin—Anorexia—Hydroxyurea—brain cancer	0.000921	0.00229	CcSEcCtD
Niacin—Hypersensitivity—Procarbazine—brain cancer	0.000919	0.00229	CcSEcCtD
Niacin—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000918	0.00477	CbGpPWpGaD
Niacin—Vision blurred—Carmustine—brain cancer	0.000902	0.00225	CcSEcCtD
Niacin—Asthenia—Procarbazine—brain cancer	0.000895	0.00223	CcSEcCtD
Niacin—Pruritus—Procarbazine—brain cancer	0.000883	0.0022	CcSEcCtD
Niacin—QPRT—Disease—IDH1—brain cancer	0.000876	0.00455	CbGpPWpGaD
Niacin—Vision blurred—Temozolomide—brain cancer	0.000871	0.00217	CcSEcCtD
Niacin—Dyspnoea—Hydroxyurea—brain cancer	0.000861	0.00215	CcSEcCtD
Niacin—Somnolence—Hydroxyurea—brain cancer	0.000859	0.00214	CcSEcCtD
Niacin—Leukopenia—Carmustine—brain cancer	0.000856	0.00213	CcSEcCtD
Niacin—Diarrhoea—Procarbazine—brain cancer	0.000854	0.00213	CcSEcCtD
Niacin—QPRT—Metabolism—BSG—brain cancer	0.000853	0.00443	CbGpPWpGaD
Niacin—Dyspepsia—Hydroxyurea—brain cancer	0.00085	0.00212	CcSEcCtD
Niacin—Hypoaesthesia—Etoposide—brain cancer	0.000846	0.00211	CcSEcCtD
Niacin—Angioedema—Temozolomide—brain cancer	0.000845	0.00211	CcSEcCtD
Niacin—Decreased appetite—Hydroxyurea—brain cancer	0.00084	0.00209	CcSEcCtD
Niacin—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000834	0.00208	CcSEcCtD
Niacin—Vertigo—Temozolomide—brain cancer	0.000831	0.00207	CcSEcCtD
Niacin—QPRT—Disease—HEY1—brain cancer	0.00083	0.00432	CbGpPWpGaD
Niacin—Leukopenia—Temozolomide—brain cancer	0.000828	0.00206	CcSEcCtD
Niacin—Pain—Hydroxyurea—brain cancer	0.000826	0.00206	CcSEcCtD
Niacin—Dizziness—Procarbazine—brain cancer	0.000825	0.00206	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—PTCH2—brain cancer	0.000823	0.00428	CbGpPWpGaD
Niacin—SLC22A5—brain—brain cancer	0.00082	0.00383	CbGeAlD
Niacin—Palpitations—Temozolomide—brain cancer	0.000817	0.00204	CcSEcCtD
Niacin—Myalgia—Carmustine—brain cancer	0.000814	0.00203	CcSEcCtD
Niacin—QPRT—Disease—DLL1—brain cancer	0.000814	0.00423	CbGpPWpGaD
Niacin—Cough—Temozolomide—brain cancer	0.000807	0.00201	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—HES5—brain cancer	0.000797	0.00414	CbGpPWpGaD
Niacin—Eye disorder—Etoposide—brain cancer	0.000794	0.00198	CcSEcCtD
Niacin—Vomiting—Procarbazine—brain cancer	0.000793	0.00198	CcSEcCtD
Niacin—NNMT—Metabolism—BSG—brain cancer	0.000793	0.00412	CbGpPWpGaD
Niacin—Flushing—Etoposide—brain cancer	0.000789	0.00197	CcSEcCtD
Niacin—Arthralgia—Temozolomide—brain cancer	0.000787	0.00196	CcSEcCtD
Niacin—Myalgia—Temozolomide—brain cancer	0.000787	0.00196	CcSEcCtD
Niacin—Rash—Procarbazine—brain cancer	0.000787	0.00196	CcSEcCtD
Niacin—Dermatitis—Procarbazine—brain cancer	0.000786	0.00196	CcSEcCtD
Niacin—Headache—Procarbazine—brain cancer	0.000782	0.00195	CcSEcCtD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000782	0.00195	CcSEcCtD
Niacin—Oedema—Carmustine—brain cancer	0.000781	0.00195	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—PTCH2—brain cancer	0.00078	0.00405	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—STRADA—brain cancer	0.000774	0.00402	CbGpPWpGaD
Niacin—Angiopathy—Etoposide—brain cancer	0.000771	0.00192	CcSEcCtD
Niacin—Dry mouth—Temozolomide—brain cancer	0.00077	0.00192	CcSEcCtD
Niacin—SLC16A1—Hemostasis—MPL—brain cancer	0.000764	0.00397	CbGpPWpGaD
Niacin—Body temperature increased—Hydroxyurea—brain cancer	0.000764	0.0019	CcSEcCtD
Niacin—Chills—Etoposide—brain cancer	0.000763	0.0019	CcSEcCtD
Niacin—Tachycardia—Carmustine—brain cancer	0.000762	0.0019	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—TRPC6—brain cancer	0.000762	0.00396	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HES5—brain cancer	0.000755	0.00393	CbGpPWpGaD
Niacin—Anaphylactic shock—Temozolomide—brain cancer	0.000755	0.00188	CcSEcCtD
Niacin—Oedema—Temozolomide—brain cancer	0.000755	0.00188	CcSEcCtD
Niacin—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000754	0.00392	CbGpPWpGaD
Niacin—Alopecia—Etoposide—brain cancer	0.000751	0.00187	CcSEcCtD
Niacin—Anorexia—Carmustine—brain cancer	0.000744	0.00186	CcSEcCtD
Niacin—Nausea—Procarbazine—brain cancer	0.000741	0.00185	CcSEcCtD
Niacin—CYP2D6—endocrine gland—brain cancer	0.00074	0.00346	CbGeAlD
Niacin—QPRT—Metabolism—IDH1—brain cancer	0.000734	0.00381	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—STRADA—brain cancer	0.000733	0.00381	CbGpPWpGaD
Niacin—Skin disorder—Temozolomide—brain cancer	0.000733	0.00183	CcSEcCtD
Niacin—SLC16A1—Hemostasis—S100A10—brain cancer	0.000732	0.00381	CbGpPWpGaD
Niacin—CYP2D6—head—brain cancer	0.00073	0.00341	CbGeAlD
Niacin—Hypotension—Carmustine—brain cancer	0.00073	0.00182	CcSEcCtD
Niacin—Hyperhidrosis—Temozolomide—brain cancer	0.000729	0.00182	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—TRPC6—brain cancer	0.000722	0.00375	CbGpPWpGaD
Niacin—Anorexia—Temozolomide—brain cancer	0.000719	0.00179	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—SHH—brain cancer	0.000717	0.00373	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000713	0.00371	CbGpPWpGaD
Niacin—Hypersensitivity—Hydroxyurea—brain cancer	0.000712	0.00177	CcSEcCtD
Niacin—Musculoskeletal discomfort—Carmustine—brain cancer	0.000711	0.00177	CcSEcCtD
Niacin—Muscle spasms—Etoposide—brain cancer	0.000711	0.00177	CcSEcCtD
Niacin—Insomnia—Carmustine—brain cancer	0.000706	0.00176	CcSEcCtD
Niacin—Paraesthesia—Carmustine—brain cancer	0.000701	0.00175	CcSEcCtD
Niacin—Dyspnoea—Carmustine—brain cancer	0.000696	0.00174	CcSEcCtD
Niacin—Somnolence—Carmustine—brain cancer	0.000694	0.00173	CcSEcCtD
Niacin—Asthenia—Hydroxyurea—brain cancer	0.000693	0.00173	CcSEcCtD
Niacin—QPRT—Disease—ENO2—brain cancer	0.000692	0.0036	CbGpPWpGaD
Niacin—QPRT—Disease—SHH—brain cancer	0.000692	0.0036	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—TRPC6—brain cancer	0.000692	0.0036	CbGpPWpGaD
Niacin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000687	0.00171	CcSEcCtD
Niacin—Insomnia—Temozolomide—brain cancer	0.000682	0.0017	CcSEcCtD
Niacin—NNMT—Metabolism—IDH1—brain cancer	0.000682	0.00354	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—SHH—brain cancer	0.00068	0.00353	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—SMO—brain cancer	0.00068	0.00353	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PTCH1—brain cancer	0.00068	0.00353	CbGpPWpGaD
Niacin—Decreased appetite—Carmustine—brain cancer	0.000679	0.00169	CcSEcCtD
Niacin—Paraesthesia—Temozolomide—brain cancer	0.000678	0.00169	CcSEcCtD
Niacin—Gastrointestinal disorder—Carmustine—brain cancer	0.000674	0.00168	CcSEcCtD
Niacin—Dyspnoea—Temozolomide—brain cancer	0.000673	0.00168	CcSEcCtD
Niacin—Somnolence—Temozolomide—brain cancer	0.000671	0.00167	CcSEcCtD
Niacin—Pain—Carmustine—brain cancer	0.000668	0.00166	CcSEcCtD
Niacin—CYP2D6—central nervous system—brain cancer	0.000667	0.00312	CbGeAlD
Niacin—Vertigo—Etoposide—brain cancer	0.000665	0.00166	CcSEcCtD
Niacin—Dyspepsia—Temozolomide—brain cancer	0.000664	0.00166	CcSEcCtD
Niacin—Leukopenia—Etoposide—brain cancer	0.000662	0.00165	CcSEcCtD
Niacin—Diarrhoea—Hydroxyurea—brain cancer	0.000661	0.00165	CcSEcCtD
Niacin—Decreased appetite—Temozolomide—brain cancer	0.000656	0.00163	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—TRPC6—brain cancer	0.000656	0.00341	CbGpPWpGaD
Niacin—CYP2D6—cerebellum—brain cancer	0.000652	0.00305	CbGeAlD
Niacin—Gastrointestinal disorder—Temozolomide—brain cancer	0.000651	0.00162	CcSEcCtD
Niacin—Loss of consciousness—Etoposide—brain cancer	0.00065	0.00162	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—ABR—brain cancer	0.000646	0.00336	CbGpPWpGaD
Niacin—Cough—Etoposide—brain cancer	0.000646	0.00161	CcSEcCtD
Niacin—Pain—Temozolomide—brain cancer	0.000645	0.00161	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—SMO—brain cancer	0.000645	0.00335	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PTCH1—brain cancer	0.000645	0.00335	CbGpPWpGaD
Niacin—Dizziness—Hydroxyurea—brain cancer	0.000639	0.00159	CcSEcCtD
Niacin—Gastrointestinal pain—Carmustine—brain cancer	0.000638	0.00159	CcSEcCtD
Niacin—SLC16A1—Transmembrane transport of small molecules—S100A10—brain cancer	0.000634	0.00329	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TRPC6—brain cancer	0.000626	0.00325	CbGpPWpGaD
Niacin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000625	0.00156	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—GLI2—brain cancer	0.000624	0.00324	CbGpPWpGaD
Niacin—Body temperature increased—Carmustine—brain cancer	0.000617	0.00154	CcSEcCtD
Niacin—Abdominal pain—Carmustine—brain cancer	0.000617	0.00154	CcSEcCtD
Niacin—Gastrointestinal pain—Temozolomide—brain cancer	0.000617	0.00154	CcSEcCtD
Niacin—Vomiting—Hydroxyurea—brain cancer	0.000614	0.00153	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—ABR—brain cancer	0.000612	0.00318	CbGpPWpGaD
Niacin—Rash—Hydroxyurea—brain cancer	0.000609	0.00152	CcSEcCtD
Niacin—Dermatitis—Hydroxyurea—brain cancer	0.000608	0.00152	CcSEcCtD
Niacin—Headache—Hydroxyurea—brain cancer	0.000605	0.00151	CcSEcCtD
Niacin—Anaphylactic shock—Etoposide—brain cancer	0.000604	0.0015	CcSEcCtD
Niacin—Urticaria—Temozolomide—brain cancer	0.000599	0.00149	CcSEcCtD
Niacin—Abdominal pain—Temozolomide—brain cancer	0.000596	0.00149	CcSEcCtD
Niacin—Body temperature increased—Temozolomide—brain cancer	0.000596	0.00149	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—GLI2—brain cancer	0.000591	0.00307	CbGpPWpGaD
Niacin—Tachycardia—Etoposide—brain cancer	0.000589	0.00147	CcSEcCtD
Niacin—Skin disorder—Etoposide—brain cancer	0.000586	0.00146	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—GLI1—brain cancer	0.000586	0.00305	CbGpPWpGaD
Niacin—Hyperhidrosis—Etoposide—brain cancer	0.000584	0.00145	CcSEcCtD
Niacin—QPRT—Metabolism—ENO2—brain cancer	0.00058	0.00301	CbGpPWpGaD
Niacin—Anorexia—Etoposide—brain cancer	0.000576	0.00143	CcSEcCtD
Niacin—Hypersensitivity—Carmustine—brain cancer	0.000575	0.00143	CcSEcCtD
Niacin—Nausea—Hydroxyurea—brain cancer	0.000574	0.00143	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—VAV1—brain cancer	0.000571	0.00297	CbGpPWpGaD
Niacin—Hypotension—Etoposide—brain cancer	0.000564	0.00141	CcSEcCtD
Niacin—Asthenia—Carmustine—brain cancer	0.00056	0.0014	CcSEcCtD
Niacin—Hypersensitivity—Temozolomide—brain cancer	0.000556	0.00139	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—GLI1—brain cancer	0.000556	0.00289	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SUFU—brain cancer	0.000556	0.00289	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—S100A10—brain cancer	0.000545	0.00283	CbGpPWpGaD
Niacin—Paraesthesia—Etoposide—brain cancer	0.000542	0.00135	CcSEcCtD
Niacin—SLC16A3—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000542	0.00282	CbGpPWpGaD
Niacin—Asthenia—Temozolomide—brain cancer	0.000541	0.00135	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—VAV1—brain cancer	0.000541	0.00281	CbGpPWpGaD
Niacin—NNMT—Metabolism—ENO2—brain cancer	0.000539	0.0028	CbGpPWpGaD
Niacin—Dyspnoea—Etoposide—brain cancer	0.000538	0.00134	CcSEcCtD
Niacin—Somnolence—Etoposide—brain cancer	0.000537	0.00134	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—GFAP—brain cancer	0.000536	0.00279	CbGpPWpGaD
Niacin—Diarrhoea—Carmustine—brain cancer	0.000534	0.00133	CcSEcCtD
Niacin—Pruritus—Temozolomide—brain cancer	0.000534	0.00133	CcSEcCtD
Niacin—CYP2D6—brain—brain cancer	0.000529	0.00247	CbGeAlD
Niacin—HCAR3—Signaling Pathways—SUFU—brain cancer	0.000527	0.00274	CbGpPWpGaD
Niacin—Decreased appetite—Etoposide—brain cancer	0.000525	0.00131	CcSEcCtD
Niacin—Gastrointestinal disorder—Etoposide—brain cancer	0.000521	0.0013	CcSEcCtD
Niacin—HCAR2—Signaling by GPCR—VAV1—brain cancer	0.000518	0.00269	CbGpPWpGaD
Niacin—Dizziness—Carmustine—brain cancer	0.000516	0.00129	CcSEcCtD
Niacin—Pain—Etoposide—brain cancer	0.000516	0.00129	CcSEcCtD
Niacin—Diarrhoea—Temozolomide—brain cancer	0.000516	0.00129	CcSEcCtD
Niacin—SLC16A1—Hemostasis—BSG—brain cancer	0.000516	0.00268	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—GFAP—brain cancer	0.000508	0.00264	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HEY1—brain cancer	0.000508	0.00264	CbGpPWpGaD
Niacin—QPRT—Disease—VAV1—brain cancer	0.0005	0.0026	CbGpPWpGaD
Niacin—Dizziness—Temozolomide—brain cancer	0.000499	0.00124	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—DLL1—brain cancer	0.000498	0.00259	CbGpPWpGaD
Niacin—Vomiting—Carmustine—brain cancer	0.000496	0.00124	CcSEcCtD
Niacin—Gastrointestinal pain—Etoposide—brain cancer	0.000494	0.00123	CcSEcCtD
Niacin—Rash—Carmustine—brain cancer	0.000492	0.00123	CcSEcCtD
Niacin—Dermatitis—Carmustine—brain cancer	0.000492	0.00123	CcSEcCtD
Niacin—HCAR3—Signaling by GPCR—VAV1—brain cancer	0.000491	0.00255	CbGpPWpGaD
Niacin—Headache—Carmustine—brain cancer	0.000489	0.00122	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—HEY1—brain cancer	0.000482	0.0025	CbGpPWpGaD
Niacin—Vomiting—Temozolomide—brain cancer	0.00048	0.0012	CcSEcCtD
Niacin—Urticaria—Etoposide—brain cancer	0.00048	0.0012	CcSEcCtD
Niacin—Body temperature increased—Etoposide—brain cancer	0.000477	0.00119	CcSEcCtD
Niacin—Abdominal pain—Etoposide—brain cancer	0.000477	0.00119	CcSEcCtD
Niacin—Rash—Temozolomide—brain cancer	0.000476	0.00119	CcSEcCtD
Niacin—Dermatitis—Temozolomide—brain cancer	0.000475	0.00118	CcSEcCtD
Niacin—Headache—Temozolomide—brain cancer	0.000473	0.00118	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—DLL1—brain cancer	0.000473	0.00246	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—VAV1—brain cancer	0.000469	0.00244	CbGpPWpGaD
Niacin—Nausea—Carmustine—brain cancer	0.000464	0.00116	CcSEcCtD
Niacin—SLC16A3—Metabolism—CYP2C9—brain cancer	0.000456	0.00237	CbGpPWpGaD
Niacin—Nausea—Temozolomide—brain cancer	0.000448	0.00112	CcSEcCtD
Niacin—Hypersensitivity—Etoposide—brain cancer	0.000445	0.00111	CcSEcCtD
Niacin—Asthenia—Etoposide—brain cancer	0.000433	0.00108	CcSEcCtD
Niacin—QPRT—Disease—HES1—brain cancer	0.00043	0.00224	CbGpPWpGaD
Niacin—Pruritus—Etoposide—brain cancer	0.000427	0.00106	CcSEcCtD
Niacin—HCAR2—Signaling Pathways—SHH—brain cancer	0.000424	0.0022	CbGpPWpGaD
Niacin—Diarrhoea—Etoposide—brain cancer	0.000413	0.00103	CcSEcCtD
Niacin—QPRT—Disease—PDGFRA—brain cancer	0.00041	0.00213	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TRPC6—brain cancer	0.000409	0.00212	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SHH—brain cancer	0.000402	0.00209	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PTCH1—brain cancer	0.000402	0.00209	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SMO—brain cancer	0.000402	0.00209	CbGpPWpGaD
Niacin—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000401	0.00208	CbGpPWpGaD
Niacin—Dizziness—Etoposide—brain cancer	0.000399	0.000995	CcSEcCtD
Niacin—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000395	0.00205	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TRPC6—brain cancer	0.000387	0.00201	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—BSG—brain cancer	0.000387	0.00201	CbGpPWpGaD
Niacin—Vomiting—Etoposide—brain cancer	0.000384	0.000957	CcSEcCtD
Niacin—HCAR3—Signaling Pathways—SMO—brain cancer	0.000381	0.00198	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PTCH1—brain cancer	0.000381	0.00198	CbGpPWpGaD
Niacin—Rash—Etoposide—brain cancer	0.000381	0.000949	CcSEcCtD
Niacin—Dermatitis—Etoposide—brain cancer	0.00038	0.000948	CcSEcCtD
Niacin—Headache—Etoposide—brain cancer	0.000378	0.000943	CcSEcCtD
Niacin—HCAR2—GPCR downstream signaling—PIK3CG—brain cancer	0.000362	0.00188	CbGpPWpGaD
Niacin—QPRT—Disease—IRS2—brain cancer	0.00036	0.00187	CbGpPWpGaD
Niacin—Nausea—Etoposide—brain cancer	0.000359	0.000894	CcSEcCtD
Niacin—HCAR3—GPCR downstream signaling—PIK3CG—brain cancer	0.000344	0.00179	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TRPC6—brain cancer	0.000338	0.00176	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—IDH1—brain cancer	0.000333	0.00173	CbGpPWpGaD
Niacin—SLCO2B1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000329	0.00171	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—PIK3CG—brain cancer	0.000329	0.00171	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—NOTCH2—brain cancer	0.000321	0.00167	CbGpPWpGaD
Niacin—QPRT—Disease—APC—brain cancer	0.000318	0.00165	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—PIK3CG—brain cancer	0.000312	0.00162	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—VAV1—brain cancer	0.000306	0.00159	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—NOTCH2—brain cancer	0.000304	0.00158	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—PIK3CG—brain cancer	0.000298	0.00155	CbGpPWpGaD
Niacin—SLC16A1—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000293	0.00152	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—VAV1—brain cancer	0.00029	0.00151	CbGpPWpGaD
Niacin—QPRT—Metabolism—PIK3CG—brain cancer	0.000266	0.00138	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—HES1—brain cancer	0.000263	0.00137	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—ENO2—brain cancer	0.000263	0.00137	CbGpPWpGaD
Niacin—HCAR2—GPCR downstream signaling—IL2—brain cancer	0.000255	0.00133	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—VAV1—brain cancer	0.000253	0.00132	CbGpPWpGaD
Niacin—SLC22A5—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000252	0.00131	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PDGFRA—brain cancer	0.000251	0.0013	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—HES1—brain cancer	0.00025	0.0013	CbGpPWpGaD
Niacin—NNMT—Metabolism—PIK3CG—brain cancer	0.000247	0.00129	CbGpPWpGaD
Niacin—QPRT—Disease—ERBB2—brain cancer	0.000247	0.00128	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—CYP2C9—brain cancer	0.000246	0.00128	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—SPP1—brain cancer	0.000243	0.00127	CbGpPWpGaD
Niacin—HCAR3—GPCR downstream signaling—IL2—brain cancer	0.000242	0.00126	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PDGFRA—brain cancer	0.000238	0.00124	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—IL2—brain cancer	0.000232	0.0012	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—SPP1—brain cancer	0.000231	0.0012	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IRS2—brain cancer	0.00022	0.00114	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—IL2—brain cancer	0.00022	0.00114	CbGpPWpGaD
Niacin—QPRT—Disease—CTNNB1—brain cancer	0.000216	0.00112	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—IL2—brain cancer	0.00021	0.00109	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—BSG—brain cancer	0.000209	0.00109	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IRS2—brain cancer	0.000209	0.00108	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—APC—brain cancer	0.000194	0.00101	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—PIK3CG—brain cancer	0.000194	0.00101	CbGpPWpGaD
Niacin—QPRT—Disease—STAT3—brain cancer	0.000188	0.000978	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—APC—brain cancer	0.000184	0.000958	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—PIK3CG—brain cancer	0.000184	0.000958	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—IDH1—brain cancer	0.00018	0.000935	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—VEGFA—brain cancer	0.000178	0.000926	CbGpPWpGaD
Niacin—HCAR2—Signaling by GPCR—EGFR—brain cancer	0.000177	0.000921	CbGpPWpGaD
Niacin—QPRT—Disease—MYC—brain cancer	0.000175	0.000908	CbGpPWpGaD
Niacin—QPRT—Disease—EGFR—brain cancer	0.000171	0.000889	CbGpPWpGaD
Niacin—HCAR3—Signaling by GPCR—EGFR—brain cancer	0.000168	0.000873	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—PIK3CG—brain cancer	0.000161	0.000836	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—RELA—brain cancer	0.000152	0.00079	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—ERBB2—brain cancer	0.000151	0.000785	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—RELA—brain cancer	0.000144	0.000749	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—ERBB2—brain cancer	0.000143	0.000744	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—ENO2—brain cancer	0.000142	0.000739	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—IL2—brain cancer	0.000137	0.000711	CbGpPWpGaD
Niacin—SLC16A3—Hemostasis—TP53—brain cancer	0.000135	0.0007	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CCND1—brain cancer	0.000133	0.000693	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—CTNNB1—brain cancer	0.000132	0.000686	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—IL2—brain cancer	0.00013	0.000674	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CCND1—brain cancer	0.000126	0.000657	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—CTNNB1—brain cancer	0.000125	0.000651	CbGpPWpGaD
Niacin—SLC16A3—Metabolism—PIK3CG—brain cancer	0.000121	0.000628	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—VEGFA—brain cancer	0.000116	0.000604	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—STAT3—brain cancer	0.000115	0.000598	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—IL2—brain cancer	0.000113	0.000588	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—VEGFA—brain cancer	0.00011	0.000573	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—STAT3—brain cancer	0.000109	0.000567	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—MYC—brain cancer	0.000107	0.000556	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—EGFR—brain cancer	0.000105	0.000544	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—MYC—brain cancer	0.000101	0.000527	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—EGFR—brain cancer	9.92e-05	0.000516	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—VEGFA—brain cancer	9.62e-05	0.0005	CbGpPWpGaD
Niacin—HCAR2—Signaling Pathways—TP53—brain cancer	8.79e-05	0.000457	CbGpPWpGaD
Niacin—HCAR3—Signaling Pathways—TP53—brain cancer	8.33e-05	0.000433	CbGpPWpGaD
Niacin—SLC16A1—Hemostasis—TP53—brain cancer	7.27e-05	0.000378	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—CYP2C9—brain cancer	6.85e-05	0.000356	CbGpPWpGaD
Niacin—SLC16A1—Metabolism—PIK3CG—brain cancer	6.52e-05	0.000339	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—BSG—brain cancer	5.83e-05	0.000303	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—IDH1—brain cancer	5.01e-05	0.00026	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—ENO2—brain cancer	3.96e-05	0.000206	CbGpPWpGaD
Niacin—CYP2D6—Metabolism—PIK3CG—brain cancer	1.82e-05	9.44e-05	CbGpPWpGaD
